Review: donepezil improves cognitive and global function in people with mild to moderate Alzheimer's disease.
نویسندگان
چکیده
Study selection and analysis: Eligible studies were randomised controlled trials comparing donepezil versus placebo in people with mild to moderate Alzheimer’s disease (MMSE criteria). Trials were undertaken and completed by 20 December 1999. Exclusions: not stated. Data were extracted for each individual study on the efficacy and safety of donepezil. Meta-analysis was carried out using fixed and random effects models, and results were tested for statistical heterogeneity.
منابع مشابه
Cognitive Rehabilitation An Effective Intervention to Decrease the Cognitive Deficits in Older Adults With Alzheimer Disease
Objectives: The aim of present study was to investigate the effect of cognitive rehabilitation, a new and non-pharmacological approach to reduce memory and other cognitive deficits in Alzheimer's disease. Methods & Materials: This study was a quasi-experimental research, in singlesubject study-with control group- and based on an A-B design. That was conducted in two groups of control and exp...
متن کاملDonepezil in Alzheimer’s disease: an evidence-based review of its impact on clinical and economic outcomes
INTRODUCTION Donepezil is indicated for the symptomatic treatment of mild to moderate Alzheimer's disease. It is a specific and reversible inhibitor of acetylcholinesterase (AChE); by increasing levels of available acetylcholine, donepezil may compensate for the loss of functioning cholinergic brain cells. AIMS This review evaluates the clinical impact of donepezil by assessing randomized con...
متن کاملA 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.
The efficacy and safety of donepezil as a treatment for patients with mild to moderate Alzheimer's disease (AD) was investigated in a multicenter, double-blind study. Patients were randomly assigned to treatment with placebo (n = 162), 5 mg/d donepezil (n = 154), or 10 mg/d donepezil (n = 157) for 24 weeks followed by a 6-week, single-blind placebo washout. The primary efficacy measures were th...
متن کاملThe effects of donepezil in Alzheimer's disease - results from a multinational trial.
Donepezil has been shown to be well tolerated and to improve cognition and global function in patients with mild to moderately severe Alzheimer's disease (AD). The current trial was undertaken to investigate further the efficacy and safety of donepezil, in a multinational setting, in patients with mild to moderately severe AD. This 30-week, placebo-controlled, parallel-group study consisted of ...
متن کاملThe effect of cognitive therapy on cognition in elderly people with Alzheimer's disease: A review article
Introduction and purpose: Elderly people often face cognitive problems due to the aging process. Decreased ability in cognitive functions leads to impaired performance in daily activities of judgment, attention, and awareness. Therefore, this study investigates different cognitive therapies on cognition in elderly people with Alzheimer's disease. Materials and Methods: Prisma method was used i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Evidence-based mental health
دوره 8 1 شماره
صفحات -
تاریخ انتشار 2005